Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1790522rdf:typepubmed:Citationlld:pubmed
pubmed-article:1790522lifeskim:mentionsumls-concept:C0006462lld:lifeskim
pubmed-article:1790522lifeskim:mentionsumls-concept:C0016365lld:lifeskim
pubmed-article:1790522lifeskim:mentionsumls-concept:C0085970lld:lifeskim
pubmed-article:1790522lifeskim:mentionsumls-concept:C0279023lld:lifeskim
pubmed-article:1790522pubmed:issue10lld:pubmed
pubmed-article:1790522pubmed:dateCreated1992-4-1lld:pubmed
pubmed-article:1790522pubmed:abstractTextThe potentiation of fluoxetine by buspirone is described in three cases of treatment-resistant depression. All three patients improved markedly with very few side-effects from the medication. The possibility of synergy between drugs that affect serotonin reuptake inhibition, 5HT1A receptors and 5HT2 receptors is discussed.lld:pubmed
pubmed-article:1790522pubmed:languageenglld:pubmed
pubmed-article:1790522pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1790522pubmed:citationSubsetIMlld:pubmed
pubmed-article:1790522pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1790522pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1790522pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1790522pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1790522pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1790522pubmed:statusMEDLINElld:pubmed
pubmed-article:1790522pubmed:monthDeclld:pubmed
pubmed-article:1790522pubmed:issn0706-7437lld:pubmed
pubmed-article:1790522pubmed:authorpubmed-author:BakishDDlld:pubmed
pubmed-article:1790522pubmed:issnTypePrintlld:pubmed
pubmed-article:1790522pubmed:volume36lld:pubmed
pubmed-article:1790522pubmed:ownerNLMlld:pubmed
pubmed-article:1790522pubmed:authorsCompleteYlld:pubmed
pubmed-article:1790522pubmed:pagination749-50lld:pubmed
pubmed-article:1790522pubmed:dateRevised2007-8-1lld:pubmed
pubmed-article:1790522pubmed:meshHeadingpubmed-meshheading:1790522-...lld:pubmed
pubmed-article:1790522pubmed:meshHeadingpubmed-meshheading:1790522-...lld:pubmed
pubmed-article:1790522pubmed:meshHeadingpubmed-meshheading:1790522-...lld:pubmed
pubmed-article:1790522pubmed:meshHeadingpubmed-meshheading:1790522-...lld:pubmed
pubmed-article:1790522pubmed:meshHeadingpubmed-meshheading:1790522-...lld:pubmed
pubmed-article:1790522pubmed:meshHeadingpubmed-meshheading:1790522-...lld:pubmed
pubmed-article:1790522pubmed:meshHeadingpubmed-meshheading:1790522-...lld:pubmed
pubmed-article:1790522pubmed:meshHeadingpubmed-meshheading:1790522-...lld:pubmed
pubmed-article:1790522pubmed:meshHeadingpubmed-meshheading:1790522-...lld:pubmed
pubmed-article:1790522pubmed:meshHeadingpubmed-meshheading:1790522-...lld:pubmed
pubmed-article:1790522pubmed:meshHeadingpubmed-meshheading:1790522-...lld:pubmed
pubmed-article:1790522pubmed:meshHeadingpubmed-meshheading:1790522-...lld:pubmed
pubmed-article:1790522pubmed:year1991lld:pubmed
pubmed-article:1790522pubmed:articleTitleFluoxetine potentiation by buspirone: three case histories.lld:pubmed
pubmed-article:1790522pubmed:affiliationUniversity of Ottawa, Ontario.lld:pubmed
pubmed-article:1790522pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1790522pubmed:publicationTypeCase Reportslld:pubmed